Glenview Capital Management - CYTEK BIOSCIENCES INC ownership

CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 90 filers reported holding CYTEK BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Glenview Capital Management ownership history of CYTEK BIOSCIENCES INC
ValueSharesWeighting
Q2 2022$5,365,000
+798.7%
500,000
+802.3%
0.13%
+1016.7%
Q1 2022$597,00055,4130.01%
Other shareholders
CYTEK BIOSCIENCES INC shareholders Q3 2022
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 2,100,000$30,912,00012.48%
Miura Global Management 820,000$12,070,0007.24%
RA Capital Management 13,381,054$196,969,0004.20%
HHLR ADVISORS, LTD. 8,757,030$128,903,0003.39%
Brown Capital Management 4,406,461$64,863,0000.91%
Perceptive Advisors 1,289,534$18,982,0000.55%
Hillsdale Investment Management Inc. 344,529$5,072,0000.46%
PURA VIDA INVESTMENTS, LLC 527,164$7,760,0000.45%
Parkwood LLC 42,336$623,0000.09%
PDT Partners, LLC 31,436$463,0000.07%
View complete list of CYTEK BIOSCIENCES INC shareholders